Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluorouracil is a pyrimidine analog and antimetabolite used as an antineoplastic agent in the treatment of various cancers. It works primarily by inhibiting thymidylate synthase after conversion to its active metabolite (FdUMP), thereby blocking DNA synthesis and leading to cell death. Fluorouracil can also be incorporated into RNA in place of uridine triphosphate (UTP), disrupting RNA processing and protein synthesis. It is used systemically for cancers such as colorectal cancer, breast cancer, gastric cancer, pancreatic cancer and topically for actinic keratosis and basal cell carcinoma[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluorouracil.